Drugs for Was-Related Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 281)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Amantadine |
Approved |
Phase 4 |
|
768-94-5 |
2130 |
Synonyms:
1 Aminoadamantane
138576_ALDRICH
1-Adamantamine
1-adamantanamine
1-Adamantanamine
1-Adamantanamine (8CI)
1-adamantylamine
1-Adamantylamine
1-aminoadamantane
1-Aminoadamantane
1-Aminotricyclo(3.3.1.1(sup 3,7))decane
665-66-7 (hydrochloride)
768-94-5
AB00514655
AbZ brand OF amantadine hydrochloride
AC-11992
AC1L1CZI
AC1Q4UAF
AC1Q5396
Adamantamine
adamantan-1-amine
adamantan-1-ylamine
Adamantanamine
ADAMANTANE,1-AMINO
Adamantylamine
Adekin
AKOS000113994
AKOS000119324
AL, amantadin
Aliud brand OF amantadine sulfate
Alliance brand OF amantadine hydrochloride
Aman
Amant
Amanta
Amanta hci azu
Amanta sulfate azu
Amantadin al
Amantadin azu
Amantadin neuraxpharm
Amantadin ratiopharm
Amantadin stada
Amantadina
Amantadina [INN-Spanish]
Amantadina juventus
Amantadina llorente
amantadine
Amantadine
Amantadine (INN)
Amantadine [INN:BAN]
Amantadine base
Amantadine Base
Amantadine HCL
amantadine hydrochloride
Amantadine hydrochloride
Amantadine sulfate
Amantadinneuraxpharm
Amantadin-neuraxpharm
Amantadinratiopharm
Amantadin-ratiopharm
Amantadinum
Amantadinum [INN-Latin]
Amanta-hci-azu
AmantaHCIAZU
Amantasulfateazu
Amanta-sulfate-azu
Amantidine
Ambap768-94-5
Aminoadamantane
Amixx
AZU, amantadin
Azupharma brand OF amantadine hydrochloride
Azupharma brand OF amantadine sulfate
BIA4304
BIDD:GT0757
Bio-0821
BPBio1_000368
BRN 2204333
BSPBio_000334
BSPBio_001570
BSPBio_001822
C06818
C10H17N
Cerebramed
CHEBI:2618
CHEMBL660
Ciba geigy brand OF amantadine hydrochloride
Ciba-geigy brand OF amantadine hydrochloride
CID2130
D07441
DB00915
Desitin brand OF amantadine hydrochloride
DivK1c_000815
Du pont brand OF amantadine hydrochloride
EINECS 212-201-2
Endantadine
endo Brand OF amantadine hydrochloride
Gen amantadine
Gen-amantadine
GenAmantadine
Gen-Amantadine
Genpharm brand OF amantadine hydrochloride
Hexal brand OF amantadine sulfate
|
HMS1791O12
HMS1989O12
Hormosan brand OF amantadine sulfate
HSDB 3202
Hydrochloride, amantadine
I14-1101
IDI1_000815
InChI=1/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H
Infecto flu
Infecto-flu
InfectoFlu
Infectopharm brand OF amantadine hydrochloride
Infex
Juventus brand OF amantadine hydrochloride
Juventus, amantadina
KBio1_000815
KBio2_000390
KBio2_002958
KBio2_005526
KBio3_001322
KBioGR_000548
KBioSS_000390
Krewel brand OF amantadine hydrochloride
L000868
Llorente brand OF amantadine hydrochloride
Llorente, amantadina
Lopac0_000004
Lopac-A-1260
LS-157049
Mantadine
Mantadix
Merz brand OF amantadine sulfate
Midantan
MolPort-001-661-700
MolPort-001-760-587
MolPort-001-791-102
NCGC00015036-01
NCGC00015036-07
NCGC00162039-01
NCGC00162039-02
NCGC00162039-03
NCGC00162039-04
NCGC00179597-01
NCIOpen2_001059
Neuraxpharm brand OF amantadine sulfate
Neuro hexal brand OF amantadine sulfate
NINDS_000815
Novartis brand OF amantadine hydrochloride
NSC 341865
NSC341865
NSC83653
Oprea1_248648
OR14310
Orion brand OF amantadine hydrochloride
Pharmascience brand OF amantadine hydrochloride
Pk-merz
Pk-Merz
PMS Amantadine
PMSAmantadine
PMS-Amantadine
Prestwick0_000407
Prestwick1_000407
Prestwick2_000407
Prestwick3_000407
Ratiopharm brand OF amantadine hydrochloride
Solvay brand OF amantadine hydrochloride
SPBio_000002
SPBio_002273
Spectrum_000030
Spectrum2_000081
Spectrum3_000291
Spectrum4_000134
Spectrum5_000772
Stada brand OF amantadine hydrochloride
Stada brand OF amantadine sulfate
Stada, amantadin
STK298781
Sulfate, amantadine
Symadine
Symmetrel
TCMDC-125869
Thiemann brand OF amantadine hydrochloride
TL8005280
Tregor
Tricyclo(3.3.1.1(3,7))-decan-1-amine
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine
Tricyclo(3.3.1.1(sup 3.7))decan-1-amine
Tricyclo(3.3.1.13,7)decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-amine
tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
tricyclo[3.3.1.1(3,7)]decane-1-amine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Tricyclo[3.3.1.1(sup3,7)]decan-1-amine
Tricyclo[3.3.1.1^3,7]decan-1-amine
tricyclo[3.3.1.1~3,7~]decan-1-amine
UNII-BF4C9Z1J53
Viregyt
Virosol
Wiregyt
WLN: L66 B6 A B- C 1B ITJ BZ
|
|
2 |
|
Dexmedetomidine |
Approved, Vet_approved |
Phase 4 |
|
113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-α,2,3-trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
113775-47-6
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
Dexdor
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
DEXMEDETOMIDINE
|
Dexmédétomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine hydrochloride
Dexmedetomidinum
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
MPV 1440
MPV-1440
NCGC00025347-01
Precedex
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
|
|
3 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-Diethylamino-2,6-dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
Leostesin
Lida-Mantle
Lidocaina
|
Lidocaína
Lidocaina [INN-Spanish]
lidocaine
Lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
Α-diethylamino-2,6-dimethylacetanilide
|
|
4 |
|
Desipramine |
Approved, Investigational |
Phase 4 |
|
50-47-5 |
2995 |
Synonyms:
(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine
10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine
10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine
3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine
3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine
5-(gamma-methylaminopropyl)iminodibenzyl
5-(gamma-Methylaminopropyl)iminodibenzyl
5-(g-Methylaminopropyl)iminodibenzyl
5-(γ-methylaminopropyl)iminodibenzyl
5-(Γ-methylaminopropyl)iminodibenzyl
50-47-5
58-28-6 (hydrochloride)
AB00053450
AC-15977
AC1L1EXQ
AKOS001681456
Apo desipramine
Apo-desipramine
Apotex brand OF desipramine hydrochloride
Aventis behring brand OF desipramine hydrochloride
Aventis brand OF desipramine hydrochloride
BPBio1_000447
BRN 1432747
BSPBio_000405
BSPBio_002137
C06943
CAS-58-28-6
CCRIS 7091
CHEBI:47781
CHEMBL72
CID2995
D07791
DB01151
DB07682
Demethylimipramine
Déméthylimipramine
Desimipramine
Desimpramine
Desipramin
Desipramina
Desipramina [INN-Spanish]
desipramine
Desipramine
Désipramine
Desipramine (D4)
Desipramine (INN)
Desipramine [INN:BAN]
Desipramine Hcl
Desipramine hydrochloride
desipraminum
Desipraminum
Desipraminum [INN-Latin]
Desmethylimipramine
Dezipramine
Dimethylimipramine
DivK1c_000190
DMI
DMI (pharmaceutical)
DMI 50475
EINECS 200-040-0
HSDB 3052
Hydrochloride, desipramine
IDI1_000190
|
KBio1_000190
KBio2_000921
KBio2_003489
KBio2_006057
KBio3_001357
KBioGR_000928
KBioSS_000921
L001089
Lopac0_000358
Lopac-D-3900
LS-60421
Methylaminopropyliminodibenzyl
MolPort-002-051-955
Monodemethylimipramine
N-(3-methylaminopropyl)iminobibenzyl
N-(3-Methylaminopropyl)iminobibenzyl
NCGC00015340-01
NCGC00015340-02
NCGC00015340-03
NCGC00015340-10
NCGC00024375-04
NINDS_000190
Norimipramine
Norpramin
Norpramine
Novartis brand OF desipramine hydrochloride
Novo desipramine
Novo-desipramine
Novopharm brand OF desipramine hydrochloride
Nu desipramine
Nu pharm brand OF desipramine hydrochloride
Nu-desipramine
Nu-pharm brand OF desipramine hydrochloride
Pentofran
Pertofran
Pertofrane
Pertrofane
Pertrofran
Petylyl
Pharmascience brand OF desipramine hydrochloride
PMS Desipramine
PMS-Desipramine
Prestwick0_000343
Prestwick1_000343
Prestwick2_000343
Prestwick3_000343
Ratio desipramine
Ratio-desipramine
Ratiopharm brand OF desipramine hydrochloride
Rhône poulenc rorer brand OF desipramine hydrochloride
Rhône-poulenc rorer brand OF desipramine hydrochloride
Sertofran
SPBio_000042
SPBio_002326
Spectrum_000441
Spectrum2_000091
Spectrum3_000379
Spectrum4_000314
Spectrum5_000833
STK735144
STOCK2S-34822
Temmler brand OF desipramine hydrochloride
UNII-TG537D343B
ZERO/006017
|
|
5 |
|
Fluoxetine |
Approved, Vet_approved |
Phase 4 |
|
54910-89-3 |
3386 |
Synonyms:
(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+/-)-Fluoxetine
(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine
(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
52341-67-0
54910-89-3
57226-07-0
59333-67-4 (hydrochloride)
AB00053774
AC-14564
AC1L1FTH
Adofen
AKOS003663021
Animex-On
Bio-0787
Biomol-NT_000152
BPBio1_000354
BPBio1_000509
BRD-A31159102-001-01-9
BRD-A31159102-003-05-6
BSPBio_000461
BSPBio_003375
C17H18F3NO
CHEBI:5118
CHEMBL41
CID3386
D00326
DB00472
Deprex
DivK1c_006819
dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
Eufor
Floxetine
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
fluoxetine
Fluoxetine
Fluoxétine
fluoxetine (Prozac)
Fluoxetine (TN)
Fluoxetine (USAN/INN)
Fluoxetine [USAN:INN:BAN]
Fluoxetine Hcl
|
Fluoxetine hydrochloride
Fluoxetine Hydrochloride
Fluoxetinum
Fluoxetinum [INN-Latin]
Fluval
Fontex
Foxetin
HMS2090H14
KBio1_001763
KBio2_002159
KBio2_004727
KBio2_007295
KBio3_002595
KBioGR_001166
KBioSS_002159
L000931
Lilly-110140
Lopac0_000558
LS-31040
Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine
MolPort-001-683-482
NCGC00015428-10
NCGC00024879-03
NCGC00024879-04
nchembio.534-comp2
N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
NSC283480
Portal
Prestwick0_000511
Prestwick1_000511
Prestwick2_000511
Prestwick3_000511
Prozac
Prozac Weekly
Pulvules
Reconcile
Reneuron
Sarafem
SPBio_001815
SPBio_002382
SpecPlus_000723
Spectrum_001679
Spectrum2_001658
Spectrum3_001648
Spectrum4_000613
Spectrum5_001518
STK734483
Symbyax
TL8003595
UNII-01K63SUP8D
|
|
6 |
|
Carbamazepine |
Approved, Investigational |
Phase 4 |
|
298-46-4 |
2554 |
Synonyms:
298-46-4
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz(b,F)azepine
5-carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
benzo[b][1]benzazepine-11-carboxamide
BIDD:GT0479
BIM-0050280.0001
Bio-0751
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
carbamazepine
Carbamazepine
Carbamazépine
Carbamazepine (JP15/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine acetate
Carbamazepine anhydrous
Carbamazepine dihydrate
Carbamazepine hydrochloride
Carbamazepine L-tartrate (4:1)
Carbamazepine phosphate
Carbamazepine sulfate (2:1)
CARBAMAZEPINE, U.S.P.
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
Carnexiv
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CID2554
CPD001227191
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
|
Equetro
Equetro (TN)
EU-0100292
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
Karbamazepin
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Lexin
Lopac0_000292
Lopac-C-4024
LS-60362
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
nchem.859-comp7
Neurotol
Neurotop retard
NINDS_000388
Novo-Carbamaz
NSC 169864
NSC169864
Nu-Carbamazepine
Oprea1_790775
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
S1693_Selleck
SAM002264603
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Stazepin
Stazepine
STK177357
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
|
|
7 |
|
Molindone |
Approved |
Phase 4 |
|
7416-34-4 |
23897 |
Synonyms:
(+-)-Molindone
(+/-)-molindone
15622-65-8 (mono-hydrochloride)
3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydro-4H-indol-4-one
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one
3-Ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)indol-4(5H)-one
65973-37-7
7416-34-4
AB00514709
AC1L2N2H
AC1Q2SRY
AC1Q6J6B
AC-7052
BPBio1_001374
BRD-A65280694-003-03-8
BSPBio_001249
C07230
C16H24N2O2
CHEBI:103799
CHEMBL460
CID23897
D08226
DB01618
endo Brand OF molindone hydrochloride
HSDB 3131
Hydrochloride, molindone
|
I14-11948
L001248
LS-83891
Moban
Molindona
Molindona [INN-Spanish]
Molindone
MOLINDONE
Molindone (INN)
Molindone (MOL)
Molindone [INN:BAN]
Molindone hydrochloride
Molindone monohydrochloride
Molindone Monohydrochloride
Molindonum
Molindonum [INN-Latin]
MolPort-005-940-887
Monohydrochloride, molindone
NCGC00162218-01
NCGC00162218-02
NCGC00162218-03
Oprea1_038890
Prestwick0_001035
Prestwick1_001035
Prestwick2_001035
Prestwick3_001035
SPBio_003100
UNII-RT3Y3QMF8N
|
|
8 |
|
Risperidone |
Approved, Investigational |
Phase 4 |
|
106266-06-2 |
5073 |
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
Belivon
BIDD:GT0262
Bio-0092
BRD-K53857191-001-04-5
BRN 4891881
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
Consta, risperdal
Consta, Risperdal
CPD000466323
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
Lopac-R-118
LS-134196
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
NCGC00015883-01
NCGC00015883-02
|
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R64,766
R-64,766
R64766
R-64766
R-64-766
Rispen
Risperdal
Risperdal (TN)
Risperdal consta
Risperdal Consta
Risperdal m-tab
Risperdal M-Tab
risperdone
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
risperidone
Risperidone
Rispéridone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
Sequinan
SMR000466323
SPBio_003078
Spiron
STK646402
TL8000230
UNII-L6UH7ZF8HC
|
|
9 |
|
Olanzapine |
Approved, Investigational |
Phase 4 |
|
132539-06-1 |
4585 135398745 |
Synonyms:
132539-06-1
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC1L1IHS
AC-665
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
Lanzac
Lilly brand of olanzapine
LS-152313
LY 170053
LY-170052
LY-170053
|
Midax
MLS000759457
MLS001165781
MLS001195646
MLS001424057
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
olanzapina
Olanzapina
olanzapine
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapine pamoate
olanzapinum
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zolafren
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa intramuscular
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa zydis
Zyprexa Zydis
|
|
10 |
|
Oxycodone |
Approved, Illicit, Investigational |
Phase 4 |
|
76-42-6 |
5284603 |
Synonyms:
(-)-14-Hydroxydihydrocodeinone
(-)-Oxycodone
(5alpha)-14-hydroxy-17-methyl-3-(methyloxy)-4,5-epoxymorphinan-6-one
124-90-3 (hydrochloride)
14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one
14-Hydroxydihydrocodeinone
25333-72-6 (Terephthalate)
4,5.alpha.-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5a-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5α-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5Α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
76-42-6
AC-16043
AC1Q4DTG
BRN 0043446
C08018
CHEBI:7852
CHEMBL656
CID5284603
Combunox
D05312
DB00497
DEA No. 9143
Dihydro-14-hydroxycodeinone
Dihydrohydroxycodeinone
Dihydrohydroxycondeinone
Dihydrone
Dihydroxycodeinone
Dinarkon
Diphydrone
EINECS 200-960-2
Endine (Australia)
Endocet
Endodan
Endone
Eubine
Eubine [France]
Eucodal
Eucodalum
Eukodal
Eutagen
HSDB 3142
Hydroxycodeinon
LS-92148
MolPort-004-285-989
Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl- (8CI)
NSC 19043
NSC19043
Ossicodone
|
Ossicodone [DCIT]
Oxanest
Oxicodona
Oxicodona [INN-Spanish]
Oxicon
Oxicone
Oxiconum
Oxikon
Oxycodeinon
Oxycodeinone
Oxycodon
oxycodone
Oxycodone
Oxycodone (USAN/INN)
Oxycodone [USAN:INN:BAN]
Oxycodone Concentrate
Oxycodone Hcl
Oxycodone hydrochloride
Oxycodone Hydrochloride
Oxycodonum
Oxycodonum [INN-Latin]
Oxycon
Oxycone
Oxycontin
Oxyfast
OxyFAST
OxyIR
Oxynorm
OxyNorm
Pancodine
Pancodone retard (United Kingdom)
Percobarb
Percodan
Percolone
PTI-821
Purdue frederick brand OF oxycodone
Remoxy
Roxicet
Roxicodone
Supendol
Supendol [Canada]
Supeudol
Tecodin
Tekodin
Tekodin (free base)
Thecodine
Thekodin
Theocodin
UNII-CD35PMG570
WLN: T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ CQ JO1 P1
|
|
11 |
|
Oxymorphone |
Approved, Investigational, Vet_approved |
Phase 4 |
|
76-41-5 |
5284604 |
Synonyms:
(-)-Oxymorphone
(14S)-14-Hydroxydihydromorphinone
(5alpha)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-one
(5alpha)-4,5-Epoxy-3,14-dihydroxyl-17-methylmorphinan-6-one
14-Hydroxydihydromorphinone
4,5-Epoxy-3,14-dihydroxy-N-methyl-6-oxomorphinan
7,8-Dihydro-14-hydroxymorphinone
76-41-5
AC-16042
Bristol-myers squibb brand OF oxymorphone hydrochloride
C08019
CHEBI:194484
CHEMBL963
CID5284604
D08323
DB01192
Dihydro-14-hydroxymorphinone
Dihydrohydroxymorphinone
Dihydroxymorphinone
EN3202
|
endo Brand OF oxymorphine HCL
endo Brand OF oxymorphone hydrochloride
FT-0080194
MolPort-003-849-766
Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-methyl- (8CI)
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)- (9CI)
Morphinone, 7,8-dihydro-14-hydroxy- (6CI,7CI)
NSC19045
Numorphan
Opana
Oximorfona
Oximorphonum
Oxymorphine
oxymorphone
Oxymorphone
Oxymorphone (INN)
Oxymorphone HCL
Oxymorphone hydrochloride
Oxymorphonum
|
|
12 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-3-Isobutyl GABA
(S+)-3-isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-isobutyl GABA
3-Isobutyl gaba
3-Isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
|
CI-1008
CID5486971
D02716
DB00230
FT-0080911
GABA, 3-isobutyl
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregabalina
Pregablin
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
|
|
13 |
|
Raclopride |
Investigational |
Phase 4 |
|
84225-95-6 |
|
Synonyms:
|
14 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
15 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
16 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
17 |
|
Central Nervous System Stimulants |
|
Phase 4 |
|
|
|
18 |
|
Quetiapine Fumarate |
|
Phase 4 |
|
111974-72-2 |
|
19 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
20 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
21 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
22 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
23 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
24 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
25 |
|
Antidepressive Agents, Tricyclic |
|
Phase 4 |
|
|
|
26 |
|
interferons |
|
Phase 4 |
|
|
|
27 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
28 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
29 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
30 |
|
Antiemetics |
|
Phase 4 |
|
|
|
31 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
32 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
33 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
34 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
35 |
|
Hormones |
|
Phase 4 |
|
|
|
36 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
37 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
38 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
Antemovis
|
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
Serotonine
sérotonine
thrombocytin
Thrombocytin
thrombotonin
Thrombotonin
|
|
39 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
40 |
|
Propranolol |
Approved, Investigational |
Phase 3 |
|
525-66-6 |
4946 |
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
13013-17-7
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
AY 64043
AY-20694
Bedranol
Beprane
Berkolol
Beta Neg
Betachron
Betadren
Betalong
Beta-Neg
beta-Propranolol
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
BPBio1_001040
b-Propranolol
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
C07407
C16H21NO2
Cardinol
Caridolol
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
cMAP_000071
Corpendol
D,L-Propranolol
D08443
DB00571
Deralin
Dexpropranolol
DivK1c_000023
Dl-Propranolol Hydrochloride
DL-Propranolol hydrochloride
Dociton
Duranol
Efektolol
EINECS 208-378-0
EINECS 235-867-6
Elbrol
etalong
Etalong
Euprovasin
Frekven
Herzbase
HMS2090L21
Hydrochloride, propranolol
ICI 45520
IDI1_000023
Ikopal
Inderal
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Inderide
INDERIDE-40/25
INDERIDE-80/25
|
Inderol
Indobloc
Innopran XL
InnoPranXL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
Lopac0_000896
LS-122410
LS-184129
Migrastat
MolPort-001-794-623
Naprilin
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Pranolol
Prano-Puren
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
propranolol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol [INN:BAN]
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol hydrochloride
Propranolol Hydrochloride
propranololo
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor line
Reducor Line
Rexigen
Sagittol
Sawatal
Servanolol
Sloprolol
SPBio_001361
SPBio_001658
SPBio_003093
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
STK735510
Sumial
Tesnol
UNII-9Y8NXQ24VQ
β-Propranolol
Β-propranolol
|
|
41 |
|
Lofexidine |
Approved, Investigational |
Phase 3 |
|
31036-80-3 |
30668 |
Synonyms:
1H-Imidazole, 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro- (9CI)
2-(1-(2,6-Dichlorophenoxy)ethyl)-4,5-dihydro-1H-imidazole
2-(a-(2,6-dichlorophenoxy)ethyl)2-imidazoline
2-(a-(2,6-Dichlorophenoxy)ethyl)2-imidazoline
2-(alpha-(2,6-dichlorophenoxy)ethyl) delta-2-imidazoline
2-(alpha-(2,6-Dichlorophenoxy)ethyl) delta-2-imidazoline
2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline
2-(Α-(2,6-dichlorophenoxy)ethyl)2-imidazoline
2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole
2-{1-[(2,6-dichlorophenyl)oxy]ethyl}-4,5-dihydro-1H-imidazole
21498-08-8 (mono-hydrochloride)
31036-80-3
AC1L1K1D
AC1Q3Q8L
Britlofex
BritLofex
C11H12Cl2N2O
CHEBI:51368
CHEMBL17860
CID30668
|
D08141
DB04948
HMS2090C03
Lofexidina
Lofexidina [inn-spanish]
Lofexidina [INN-Spanish]
lofexidine
Lofexidine
Lofexidine (INN)
Lofexidine [INN:BAN]
Lofexidine hydrochloride
Lofexidine monohydrochloride
Lofexidine mono-hydrochloride
Lofexidine, (+-)-isomer
Lofexidinum
Lofexidinum [inn-latin]
Lofexidinum [INN-Latin]
LS-79612
MolPort-003-848-405
|
|
42 |
|
Norepinephrine |
Approved |
Phase 2, Phase 3 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(-)-Arterenol free base
(−)-noradrenaline
(-)-Noradrenaline
(-)-NORADRENALINE
(−)-norepinephrine
(-)-Norepinephrine
(+)-Palmitoylcarnitine
(2S)-2-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}pentyl]amino}-4-phenylbutanoate
(3R)-3-(Hexadecanoyloxy)-4-(trimethylazaniumyl)butanoate
(3R)-3-(Hexadecanoyloxy)-4-(trimethylazaniumyl)butanoic acid
(3R)-3-Palmitoyloxy-4-(trimethylammonio)butanoate
(3R)-3-Palmitoyloxy-4-(trimethylammonio)butanoic acid
(3S)-3-Hexadecanoyloxy-4-(trimethylammonio)butanoate
(3S)-3-Hexadecanoyloxy-4-(trimethylammonio)butanoic acid
(3S)-3-Palmitoyloxy-4-(trimethylammonio)butanoate
(3S)-3-Palmitoyloxy-4-(trimethylammonio)butanoic acid
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-Noradrenaline
(R)-norepinephrine
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
2'-(Dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) adenosine 5'-ester with 1,4-dihydro-1-b-D-ribofuranosylnicotinamide
2'-(Dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) adenosine 5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosylnicotinamide
2-Ketoadipate
2-Keto-adipate
2-Ketoadipic acid
2-Oxoadipate
2-Oxoadipic acid
2-oxo-Hexanedioate
2-Oxohexanedioate
2-oxo-Hexanedioic acid
2-Oxohexanedioic acid
2-Oxohexanedionic acid
3-Carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-1-propanaminium
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
Abbott brand OF levophed bitartrate
AC1L96ZT
Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) p'-5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) p'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide
Adrenor
a-Ketoadipate
a-Ketoadipic acid
Aktamin
ALBB-006229
alpha-Ketoadipate
alpha-Ketoadipic acid
alpha-Oxoadipate
alpha-Oxoadipic acid
a-Oxoadipate
a-Oxoadipic acid
Arterenol
Aventis brand OF norepinephrine hydrochloride
beta-NADPH
beta-Nicotinamide-adenine-dinucleotide-phosphorate
beta-Nicotinamide-adenine-dinucleotide-phosphoric acid
Bitartrate, levophed
Bitartrate, noradrenaline
Bitartrate, norepinephrine
bmse000404
b-NADPH
b-Nicotinamide-adenine-dinucleotide-phosphorate
b-Nicotinamide-adenine-dinucleotide-phosphoric acid
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
Dihydrocodehydrogenase II
Dihydronicotinamide adenine dinucleotide phosphate
Dihydronicotinamide adenine dinucleotide-p
Dihydrotriphosphopyridine nucleotide reduced
DivK1c_000230
D-Palmitylcarnitine
EINECS 200-096-6
Hexadecanoylcarnitine
Hexadecanoyl-L-carnitine
Hexadecenoyl carnitine
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
Hydrochloride, norepinephrine
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L(-)-Palmitylcarnitine
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
|
L-3,4-dihydroxyphenylethanolamine
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-Arterenol
L-Carnitine palmitoyl ester
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
Levophed bitartrate
L-noradrenaline
L-Noradrenaline
L-Norepinephrine
L-NOREPINEPHRINE
L-Palmitoyl-L-carnitine
LS-42676
LT03330026
LT4
NADP-reduced
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
Nicotinamide adenine dinucleotide phosphate - reduced
Nicotinamide-adenine-dinucleotide-phosphorate
Nicotinamide-adenine-dinucleotide-phosphoric acid
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
noradrenaline
Noradrenaline
Nor-adrenaline
Noradrenaline (JP15)
Noradrenaline bitartrate
Noradrénaline tartrate renaudin
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
norepinefrina
Norepinefrina
Norepinephrin D-tartrate (1:1)
norepinephrine
Norepinephrine
Norépinéphrine
Norepinephrine (INN)
Norepinephrine [INN:JAN]
Norepinephrine bitartrate
Norepinephrine D-tartrate (1:1)
Norepinephrine hydrochloride
Norepinephrine hydrochloride, (+)-isomer
Norepinephrine hydrochloride, (+,-)-isomer
Norepinephrine l-Tartrate (1:1)
Norepinephrine L-tartrate (1:1)
Norepinephrine L-tartrate (1:1), (+,-)-isomer
Norepinephrine L-tartrate (1:1), monohydrate
Norepinephrine L-tartrate (1:1), monohydrate, (+)-isomer
Norepinephrine L-tartrate (1:2)
Norepinephrine L-tartrate, (+)-isomer
Norepinephrine Noradrenalin
Norepinephrine, (+)-isomer
Norepinephrine, (+,-)-isomer
norepinephrinum
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
Nor-epirenan
O-Hexadecanoyl-(R)-carnitine
O-Hexadecanoyl-R-carnitine
Oxoadipate
Palmitoyl D-carnitine
Palmitoyl-(-)-carnitine
Palmitoylcarnitine
Palmitoyl-L-carnitine
Palmitylcarnitine
Palmityl-L-carnitine
PDSP1_001111
PDSP2_001095
Reduced codehydrase II
Reduced coenzyme II
Reduced cozymase II
Reduced triphosphopyridine nucleotide
Renaudin brand OF norepinephrine bitartrate
Renaudin, noradrénaline tartrate
SGCUT00123
SPBio_001048
Spectrum_001009
SPECTRUM1500436
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
STK503776
Sympathin e
Sympathin E
Tartrate renaudin, noradrénaline
to_000024
Triphosphopyridine nucleotide reduced
UNII-X4W3ENH1CV
|
|
43 |
|
Selegiline |
Approved, Investigational, Vet_approved |
Phase 3 |
|
14611-51-9 |
26757 5195 |
Synonyms:
(-)-(N)-Methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-amine
(-)-Deprenil
(−)-selegiline
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine
(R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine
(R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin
14611-51-9
14611-52-0 (hydrochloride)
2079-54-1 (deprenyl.hydrochloride)
AC1L1BTZ
AC1Q2860
AKOS000281115
Anipryl
Apo-Selegiline
BPBio1_000687
BRD-K86434416-001-02-7
BRD-K86434416-003-03-1
Bristol myers squibb brand OF selegiline
Bristol-myers squibb brand OF selegiline
BSPBio_000623
BSPBio_001589
C07245
C13H17N
Carbex
CHEBI:9086
CHEMBL972
CID26757
D03731
DB01037
Deprenalin
Deprenil
Deprenyl
Eldepryl
Emsam
Emsam (TN)
Gen-Selegiline
HMS1791P11
HMS1989P11
HMS2089D09
Humex
Hydrochloride, selegiline
Jumex
L-Deprenalin
L-Deprenyl
|
l-E 250
LS-30156
MolPort-000-883-771
NCGC00024994-01
NCGC00024994-02
NCGC00024994-03
NCGC00024994-04
N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-yn-1-amine
N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine
Novo-Selegiline
Nu-Selegiline
Prestwick0_000552
Prestwick1_000552
Prestwick2_000552
Prestwick3_000552
Sd Deprenyl
Selegeline Hcl
Selegilina
Selegilina [INN-Spanish]
selegiline
Selegiline
Selegiline (USAN/INN)
Selegiline [INN:BAN]
Selegiline hydrochloride
Selegiline hydrochloride, (R)-isomer
Selegiline hydrochloride, (R,S)-isomer
Selegiline hydrochloride, (S)-isomer
Selegiline Transdermal System (STS) patch
Selegiline valeant brand
Selegiline, (R)-isomer
Selegiline, (R)-Isomer
Selegiline, (R,S)-isomer
Selegiline, (S)-isomer
Selegilinum
Selegilinum [INN-Latin]
Selegyline
SPBio_002544
STK640578
Tocris-1095
UNII-2K1V7GP655
Valeant brand OF selegiline
Yumex
Zelapar
ZINC19632633
|
|
44 |
|
Biperiden |
Approved, Investigational |
Phase 2, Phase 3 |
|
514-65-8 |
2381 |
Synonyms:
1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol
1-(Bicyclo(2.2.1)hept-5-en-2alpha-yl)-1-phenyl-3-piperidinopropanol
1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol
1235-82-1 (hydrochloride)
1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol
1-Bicycloheptenyl-1-phenyl-3-piperidino-propanol-1
1-Piperidinepropanol, .alpha.-bicyclo[2.2.1]hept-5-en-2-yl-.alpha.-phenyl-, hydrochloride
3-Piperidino-1-phenyl-1-bicyclo(2.2.1)hepten-(5)-yl-propanol-(1)
3-Piperidino-1-phenyl-1-bicyclo(2.2.1)hepten-(5)-yl-propanol-(1) [German]
3-Piperidino-1-phenyl-1-bicycloheptenyl-1-propanol
514-65-8
5-20-02-00242 (Beilstein Handbook Reference)
a-5-Norbornen-2-yl-a-phenyl-1-piperidinepropanol
a-Bicyclo[2.2.1]hept-5-en-2-yl-a-phenyl-1-piperidinepropanol
AC1L1DJT
Akineton
Akineton (TN)
alpha-(Bicyclo(2.2.1)hept-5-en-2-yl)-alpha-phenyl-1-piperidino propanol
alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
Beperiden
biperiden
Biperiden
Biperiden (JAN/USP/INN)
Biperiden [USAN:BAN:INN:JAN]
Biperiden [USAN:INN:BAN:JAN]
Biperiden hydrochloride
Biperiden, 1R-(1 alpha,2 alpha(r*),4 alpha)-isomer
Biperiden, 1S-(1 alpha,2 alpha(r*),4 alpha)-isomer
Biperidene
|
Biperidene [INN-French]
Biperidene hydrochloride
Biperideno
Biperideno [INN-Spanish]
Biperidenum
Biperidenum [INN-Latin]
Biperidine
BRN 0290038
C07941
CHEBI:3112
CHEMBL1101
CID2381
D00779
DB00810
EINECS 208-184-6
HMS2093N17
HSDB 7639
Hydrochloride, biperiden
KL 373
L001222
LS-116068
MolPort-003-666-707
NCGC00182965-02
NCIOpen2_009564
PDSP1_000821
PDSP2_000808
Prestwick0_000502
Prestwick1_000502
Prestwick2_000502
SPBio_002344
UNII-0FRP6G56LD
Α-5-norbornen-2-yl-α-phenyl-1-piperidinepropanol
Α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-1-piperidinepropanol
|
|
45 |
|
Nicotinamide |
Approved, Investigational |
Phase 2, Phase 3 |
|
98-92-0 |
936 |
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
37321-14-5
3-Carbamoylpyridine
3-pyridinecarboxamide
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC1L1ACZ
AC1Q4ZFV
AC-907/25014114
Acid amide
AI3-02906
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Astra Brand of Niacinamide
Austrovit PP
b 3, Vitamin
B 3, Vitamin
b3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
beta-Pyridinecarboxamide
bmse000281
b-Pyridinecarboxamide
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
Factor PP
Hansamid
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
Jenapharm, nicotinsäureamid
LS-2051
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
Merck Brand of Niacinamide
MLS000069714
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
Nandervit-N
NCGC00093354-03
NCGC00093354-04
nchembio.154-comp4
nchembio.73-comp6
Niacevit
Niacin
niacin - Vitamin B3
niacinamide
Niacinamide
Niacinamide (USP)
Niacinamide [USAN]
|
Niacinamide astra brand
Niacinamide Astra Brand
Niacinamide jenapharm brand
Niacinamide Jenapharm Brand
Niacinamide merck brand
Niacinamide Merck Brand
Niacinamide pharmagenix brand
Niacinamide Pharmagenix Brand
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
nicotinamide
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid [German]
Nicotinsaureamid Jenapharm
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
NSC 13128
NSC13128
NSC27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
Pharmagenix Brand of Niacinamide
PP-Faktor
Propamine a
pyridine-3-carboxamide
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
Savacotyl
SGCUT00176
SMR000058212
to_000073
UNII-25X51I8RD4
Vi-nicotyl
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin b 3
Vitamin B 3
Vitamin b3
Vitamin H1
vitamin PP
Vitamin PP
Witamina PP
WLN: T6NJ CVZ
ZINC00005878
β-pyridinecarboxamide
Β-pyridinecarboxamide
|
|
46 |
|
Mineral oil |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
8042-47-5 |
|
Synonyms:
Food Grade Mineral Oil
Heavy Liquid Petrolatum
Heavy mineral oil
Liquid Paraffin
Liquid Petrolatum
Mineral Oil (high Viscosity)
|
Mineral Oil, Heavy
Paraffin Oil
Paraffin, Liquid
Paraffinum Liquidum
Petrolatum, Liquid
White Mineral Oil
|
|
47 |
|
Tocopherol |
Approved, Investigational |
Phase 2, Phase 3 |
|
1406-66-2 |
|
Synonyms:
Methyltocols
tocoferol
tocoferoles
|
|
|
48 |
|
Methadone |
Approved |
Phase 3 |
|
76-99-3 |
4095 |
Synonyms:
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(+)-Methadone
(+-)-Methadone
(+/-)-methadone
(+/-)-Methadone
(+/-)-methadone hydrochloride
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(±)-methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
Adanon
Adanon hydrochloride
AddiCare brand OF methadone hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
AN 148
AN-148 (*Hydrochloride*)
Biodone
Biomet brand OF methadone hydrochloride
Biscuits
BRN 3213667
BRN 3213668
BRN 3213669
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
DB00333
DEA No. 9250
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
DivK1c_000963
dl-Methadone
DL-Methadone
DL-Methadone hydrochloride
d-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Esteve brand OF methadone hydrochloride
Fenadon
Fenadone
Fenadone (*Hydrochloride*)
Generics brand OF methadone hydrochloride
GlaxoSmithKline brand OF methadone hydrochloride
Heptadon
|
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
HSDB 3119
Hydrochloride, methadone
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L000874
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
l-Methadone
L-Polamidon
l-Polamivet
LS-74485
LS-74486
LS-74487
Mallinckrodt brand OF methadone hydrochloride
Martindale brand OF methadone hydrochloride
Mecodin
Mephenon
Metadol
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methaddict
Methadon
Methadona
Methadona [Spanish]
methadone
Methadone
Methadone (BAN)
Methadone [INN:BAN]
Methadone HCL
Methadone HCL Intensol
Methadone hydrochloride
Methadone M
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Methex
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Pharmascience brand OF methadone hydrochloride
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Phymet
Physeptone
Pinadone
Pinewood brand OF methadone hydrochloride
Polamidon
Polamidone
Polamivet
Racemic methadone
Rosemont brand OF methadone hydrochloride
Roxane brand OF methadone hydrochloride
S-(+)-Methadone
Sedo-Rapide
Symoron
Tussol
UNII-UC6VBE7V1Z
Westadone
Yamanouchi brand OF methadone hydrochloride
|
|
49 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 3 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-phenethyl-4-N-propionylanilinopiperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
Cephalon brand OF fentanyl buccal oravescent
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
fentanyl
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl [INN:BAN]
Fentanyl CII
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
Fentanyl-50
|
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
Fentora
HSDB 3329
IONSYS
Janssen pharmaceutica brand OF fentanyl
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
Nasalfent
NCGC00168252-01
N-phenethyl-4-(N-propionylanilino)piperidine
N-Phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
Transmucosal oral fentanyl citrate
UNII-UF599785JZ
|
|
50 |
|
Vitamin E |
Approved, Nutraceutical, Vet_approved |
Phase 2, Phase 3 |
|
59-02-9 |
14985 |
Synonyms:
(+)-2R,4’R,8’R-α-Tocopherol
(+)-2R,4'R,8'R-alpha-Tocopherol
(+)-2R,4'R,8'R-α-Tocopherol
(+)-alpha-Tocopherol
(+)-a-Tocopherol
(+)-α-tocopherol
(+)-α-Tocopherol
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4’R,8’R)-α-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'r,8'r)-a-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(2R,4'R,8'R)-α-Tocopherol
(all-R)-alpha-Tocopherol
(all-R)-α-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-α-tocopherol
(R,R,R)-α-Tocopherol
3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-(2R)-2H-1-benzopyran-6-ol
5,7,8-trimethyltocol
5,7,8-Trimethyltocol
a-D-Tocopherol
alpha-delta-Tocopherol
alpha-D-Tocopherol
alpha-tocopherol
alpha-Tocopherol
alpha-Vitamin E
|
Amino-Opti-E
Aquasol E
a-Tocopherol
D-alpha-Tocopherol
Daltose
D-a-Tocopherol
delta-alpha-Tocopherol
Denamone
d-α-tocopherol
D-α-tocopherol
E-200 I.U. Softgels
E-Complex-600
E-Ferol
Eprolin
E-Vitamin succinate
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-Tocopherol
RRR-alpha-Tocopheryl
Tocopherol
Vitamin e
Vitamin ea
Vitamin Plus E Softgells
Vitec
α-D-Tocopherol
α-Tocopherol
α-Vitamin E
|
|
Interventional clinical trials:
(show top 50)
(show all 646)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Cognitive Correlates of Substance Abuse, Part 1 |
Unknown status |
NCT00000346 |
Phase 4 |
|
2 |
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings |
Unknown status |
NCT00124358 |
Phase 4 |
Buprenorphine |
3 |
Comparison Between Dexmedetomidine and Lidocaine as an Adjuvant to General Anesthesia in Patients Undergoing Major Abdominal Surgeries |
Unknown status |
NCT03600493 |
Phase 4 |
Dexmedetomidine;Lidocaine |
4 |
On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings |
Completed |
NCT00317460 |
Phase 4 |
|
5 |
Efficacy of Quetiapine in the Reduction of Cocaine Use and Cravings in Individuals With Cocaine Dependence |
Completed |
NCT00232336 |
Phase 4 |
quetiapine |
6 |
Methylphenidate Raclopride PET Test |
Completed |
NCT00015301 |
Phase 4 |
Methylphenidate |
7 |
Modeling Impaired Judgement in Cocaine Abusers |
Completed |
NCT00015236 |
Phase 4 |
|
8 |
Brain Changes in Stimulant Dependent Subjects |
Completed |
NCT00000343 |
Phase 4 |
|
9 |
Feasibility, Mechanism of Action and Potential Side Effects of Extended Release Depot Naltrexone in Opioid Dependent Patients |
Completed |
NCT01471145 |
Phase 4 |
Naltrexone |
10 |
Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection |
Completed |
NCT02616523 |
Phase 4 |
Dexmedetomidine;Lidocaine;Fentanyl |
11 |
Evaluation of Preference for a Buprenorphine-based Maintenance Therapy, After a Switch From Buprenorphine Alone (Subutex®) to the Buprenorphine/Naloxone Combination (Suboxone®), in Opioid-dependent Patients With Buprenorphine Maintenance Therapy |
Completed |
NCT00684073 |
Phase 4 |
buprenorphine;buprenorphine/naloxone |
12 |
Methamphetamine Abuse Pharmacology in Patients With AIDS |
Completed |
NCT00000321 |
Phase 4 |
Desipramine |
13 |
Feasibility Study of Take-Home LAAM Medication |
Completed |
NCT00000300 |
Phase 4 |
LAAM |
14 |
Assessment of Hepatic Function in Alcoholic Patients Administered Therapeutic Dosing of Acetaminophen- a Multicenter Study |
Completed |
NCT00402571 |
Phase 4 |
acetaminophen |
15 |
Substance Dependent Teens - Impact of Treating Depression Study 1 |
Completed |
NCT00061113 |
Phase 4 |
Fluoxetine + outpatient cognitive behavioral therapy;fluoxetine;placebo + CBT |
16 |
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence |
Completed |
NCT00015275 |
Phase 4 |
|
17 |
Abuse Liability of Controlled-Release Oxycodone Formulations |
Completed |
NCT02101840 |
Phase 4 |
Apo-Oxycodone CR®;OxyNEO®;Placebo |
18 |
Hepatic Function Following Five Days of Therapeutic Dosing of Acetaminophen in Alcoholics |
Completed |
NCT00427206 |
Phase 4 |
acetaminophen (4g/day);placebo |
19 |
Starting Treatment With Agonist Replacement Therapies (START) |
Completed |
NCT00315341 |
Phase 4 |
Buprenorphine/naloxone;Methadone |
20 |
Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks |
Completed |
NCT00194480 |
Phase 4 |
Pegylated Interferon |
21 |
Pharmacotherapy and Intensive Treatment |
Completed |
NCT00000218 |
Phase 4 |
Carbamazepine |
22 |
Neurocognitive Effects of Opiate Agonist Treatment |
Completed |
NCT01733693 |
Phase 4 |
Buprenorphine;Methadone |
23 |
VIVITROL® (Naltrexone for Extended Release Injectable Suspension (XR-NTX)) for Opioid Dependent Inmates Released From Prison |
Completed |
NCT01563718 |
Phase 4 |
naltrexone for extended release injectable suspension |
24 |
Drug Contextual Conditioning With in Humans: Causes and Consequences |
Completed |
NCT03075501 |
Phase 4 |
Stimulant or sedative;Placebo |
25 |
A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings |
Completed |
NCT02978417 |
Phase 4 |
Naltrexone for extended-release injectable suspension;Oral naltrexone |
26 |
Treatment of Schizophrenia and Related Disorders in Children and Adolescents |
Completed |
NCT00053703 |
Phase 4 |
Risperidone;Olanzapine (enrollment closed in this treatment);Molindone |
27 |
"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing" |
Not yet recruiting |
NCT04478838 |
Phase 4 |
Risperidone;Olanzapine |
28 |
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioid Analgesic Therapy for Chronic Pain. |
Terminated |
NCT02741076 |
Phase 4 |
Structured discontinuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER);Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER) |
29 |
Evaluation of Pregabalin's Abuse Liability and Its Effects on Benzodiazepine Withdrawal Symptoms in Inpatients Undergoing Medically Assisted Benzodiazepine Withdrawal |
Terminated |
NCT02423018 |
Phase 4 |
Pregabalin;Placebo |
30 |
Brain Imaging: Cocaine Effects & Medication Development |
Withdrawn |
NCT00000270 |
Phase 4 |
Cocaine |
31 |
Medication Development for Cocaine Dependence |
Unknown status |
NCT00249691 |
Phase 3 |
Topiramate + Cognitive Behavioral Therapy;Placebo + Cognitive Behavioral Therapy |
32 |
Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study |
Unknown status |
NCT02789982 |
Phase 3 |
β-adrenergic blocker propranolol |
33 |
Naltrexone and CBT for Problem-drinking MSM |
Completed |
NCT00444418 |
Phase 3 |
Naltrexone |
34 |
Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial of At-Home Versus In-Office Buprenorphine Induction |
Completed |
NCT00684554 |
Phase 2, Phase 3 |
Buprenorphine |
35 |
Voucher-Based Incentives in a Prevention Setting |
Completed |
NCT00607269 |
Phase 2, Phase 3 |
|
36 |
Adolescent Drug and HIV Prevention in South Africa |
Completed |
NCT00336180 |
Phase 2, Phase 3 |
|
37 |
CBT And Venlafaxine Treatments For Anxiety In Alcoholism |
Completed |
NCT00248612 |
Phase 2, Phase 3 |
Venlafaxine |
38 |
Motivational Enhancement for Spanish Speaking Individuals |
Completed |
NCT00078169 |
Phase 3 |
|
39 |
Women's Treatment for Trauma and Substance Use Disorders |
Completed |
NCT00078156 |
Phase 3 |
|
40 |
Telephone Enhancement Procedure (TELE) for Continuing Care |
Completed |
NCT00067171 |
Phase 3 |
|
41 |
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics |
Completed |
NCT00033007 |
Phase 3 |
|
42 |
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse |
Completed |
NCT00032994 |
Phase 3 |
|
43 |
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence |
Completed |
NCT00032929 |
Phase 3 |
Selegiline |
44 |
Combining Behavioral Treatment With Agonist Maintenance |
Completed |
NCT00000311 |
Phase 3 |
Buprenorphine;methadone |
45 |
Effect of Nefazodone on Relapse in Females With Cocaine Abuse |
Completed |
NCT00000293 |
Phase 3 |
Nefazodone |
46 |
Maternal Opioid Treatment: Human Experimental Research |
Completed |
NCT00271219 |
Phase 3 |
Methadone;Buprenorphine |
47 |
Job Seekers Training for Patients With Drug Dependence |
Completed |
NCT00102362 |
Phase 3 |
|
48 |
Multicenter Clinical Trial of Buprenorphine |
Completed |
NCT00000207 |
Phase 3 |
Buprenorphine |
49 |
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence |
Completed |
NCT01848054 |
Phase 3 |
Buprenorphine/naloxone sublingual tablets;Buprenorphine |
50 |
Buprenorphine Group Medical Visits for Drug Users at Risk for HIV |
Completed |
NCT02526212 |
Phase 3 |
Buprenorphine |
|